Background The lack of uniformity in the definition of treatment resistant depression (TRD)
within the Asia-Pacific (APAC) region may have implications for patient management. We …

Background Treatment resistant depression (TRD) characterizes a subgroup of 10–30% of
patients with major depressive disorder, and is associated with considerable morbidity and …

Treatment resistant depression (TRD) is a serious public health problem. It is estimated that
around 20-40% of patients with a major depressive episode (whether monopolar or bipolar) …

Abstract Treatment-resistant depression (TRD) is a subset of Major Depressive Disorder
which does not respond to traditional and first-line therapeutic options. There are several …

BACKGROUND: Treatment resistant depressant (TRD) is classified in different staging
models, but these are not used routinely. We aimed to identify staging models for TRD and …

Major depressive disorder is a debilitating disease that imposes significant social and
economic burdens not only on patients but also on society. Although various treatment …

(1) Background: Major depressive disorder (MDD) is one of the most prevalent psychiatric
disorders worldwide. Although several antidepressant drugs have been developed, up to …

Background Treatment‐resistant depression (TRD) is a debilitating chronic mental illness
that confers increased morbidity and mortality, decreases the quality of life, impairs …

There is considerable diversity in how treatment-resistant depression (TRD) is defined.
However, every definition incorporates the concept that patients with TRD have not …

Abstract Treatment-resistant depression (TRD) is a major contributor to the disability caused
by major depressive disorder (MDD). Primary care electronic health records provide an …